These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 23491504)
1. [Utility of positron emission tomography with 18F-FDG in a case of juvenile recurrent respiratory papillomatosis]. Navales I; Paredes P; Cols M; Perissinotti A; Vancells M; Pons F Rev Esp Med Nucl Imagen Mol; 2013; 32(6):387-9. PubMed ID: 23491504 [TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung. Tatci E; Gokcek A; Unsal E; Cimen F; Demirag F; Yazici S; Ozmen O Clin Nucl Med; 2015 Oct; 40(10):802-4. PubMed ID: 26204210 [TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024 [TBL] [Abstract][Full Text] [Related]
14. [Positron tomography with 18F-fluorodeoxyglucose in the preoperative evaluation of gall bladder lesions suspicious of malignancy. Diagnostic utility and clinical impact]. Ramos-Font C; Gómez Río M; Rodríguez-Fernández A; Sánchez Sánchez R; Llamas Elvira JM Rev Esp Med Nucl; 2011; 30(5):267-75. PubMed ID: 21612846 [TBL] [Abstract][Full Text] [Related]
15. Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses. Dennis K; Hay JH; Wilson DC Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e168-72. PubMed ID: 22944464 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions. Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787 [TBL] [Abstract][Full Text] [Related]
18. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911 [TBL] [Abstract][Full Text] [Related]
19. Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy. Carnaghi C; Tronconi MC; Rimassa L; Tondulli L; Zuradelli M; Rodari M; Doci R; Luttmann F; Torzilli G; Rubello D; Al-Nahhas A; Santoro A; Chiti A Nucl Med Rev Cent East Eur; 2007; 10(1):12-5. PubMed ID: 17694495 [TBL] [Abstract][Full Text] [Related]
20. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant? Kumar R; Hawkins RA; Yeh BM; Wang ZJ Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]